evodiamine has been researched along with Adenocarcinoma Of Kidney in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cheng, S; Du, YM; Hou, XD; Liu, XM; Yuan, XL; Zhang, P; Zhang, ZF | 1 |
Chen, YC; Chien, CC; Chiu, WT; Wu, WS | 1 |
2 other study(ies) available for evodiamine and Adenocarcinoma Of Kidney
Article | Year |
---|---|
Cytological Assessments and Transcriptome Profiling Demonstrate that Evodiamine Inhibits Growth and Induces Apoptosis in a Renal Carcinoma Cell Line.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma, Renal Cell; Cell Line, Tumor; Cell Movement; Cell Proliferation; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Neoplasm Proteins; Quinazolines; Signal Transduction; Transcriptome | 2017 |
Protein Kinase RNA-Like Endoplasmic Reticulum Kinase-Mediated Bcl-2 Protein Phosphorylation Contributes to Evodiamine-Induced Apoptosis of Human Renal Cell Carcinoma Cells.
Topics: Adenine; Animals; Anthracenes; Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma, Renal Cell; Caspase 3; Cell Line, Tumor; eIF-2 Kinase; Gene Expression Regulation; Humans; Indoles; JNK Mitogen-Activated Protein Kinases; Kidney Neoplasms; Male; Membrane Potential, Mitochondrial; Mice, Nude; Mitogen-Activated Protein Kinases; Phosphatidylinositol 3-Kinases; Phosphorylation; Poly(ADP-ribose) Polymerases; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-bcl-2; Quinazolines; Signal Transduction; Tumor Burden; Xenograft Model Antitumor Assays | 2016 |